XML 15 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net loss $ (20,311) $ (13,963)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 628 587
Stock-based compensation 2,052 1,406
Change in fair value of SAFEs (including related party amounts of $0 and $217, respectively)   268
Accretion of discounts and amortization of premiums on investments, net (723) (368)
Changes in operating assets and liabilities:    
Accounts receivable (including related party amounts of $0 and $(251), respectively)   215
Other receivables (including related party amounts of $(11) and $(79), respectively) (88) (180)
Prepaid expenses and other current assets (750) (936)
Other long-term assets 254 31
Accounts payable (including related party amounts of $(270) and $772, respectively) 41 851
Accrued expenses (including related party amounts of $(632) and $(1,896), respectively) (931) (3,042)
Operating lease right-of-use asset and lease liabilities, net (13) 45
Net cash used in operating activities (19,841) (15,086)
Investing activities:    
Purchases of property and equipment (511) (18)
Purchases of investments (18,518) (6,200)
Maturities of investments 29,000 16,000
Net cash provided by investing activities 9,971 9,782
Financing activities:    
Proceeds from exercise of stock options 138  
Proceeds from purchase of ESPP shares 134  
Payments on finance leases (33)  
Net cash provided by financing activities 239  
Net decrease in cash, cash equivalents and restricted cash (9,631) (5,304)
Cash, cash equivalents and restricted cash at beginning of period 40,493 53,762
Cash, cash equivalents and restricted cash at end of period 30,862 48,458
Reconciliation of cash, cash equivalents and restricted cash to the balance sheet:    
Cash and cash equivalents 30,401 48,200
Restricted cash 461 258
Total cash, cash equivalents and restricted cash 30,862 48,458
Supplemental disclosures of noncash activities:    
Right-of-use asset obtained in exchange for new operating lease liability 442  
Property and equipment purchases in accounts payable and accrued expenses $ 882 13
Deferred offering costs in accounts payable and accrued expenses   $ 286